The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells

被引：26

作者：

Moniri, M. R. ^{[1
]}

Dai, L-J ^{[1
,2
]}

Warnock, G. L. ^{[1
]}

机构：

[1] Univ British Columbia, Dept Surg, Vancouver, BC V5Z 1L8, Canada

[2] Hubei Univ Med, Taihe Hosp, Hubei Key Lab Stem Cell Res, Shiyan, Peoples R China

来源：

CANCER GENE THERAPY | 2014年 / 21卷 / 01期

关键词：

pancreatic cancer; mesenchymal stem cells; MARROW STROMAL CELLS; BONE-MARROW; IN-VITRO; PTEN EXPRESSION; GROWTH-FACTOR; PROGENITOR CELLS; BETA-CATENIN; TUMOR STROMA; T-CELLS; INTRAVENOUS DELIVERY;

D O I：

10.1038/cgt.2013.83

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Mesenchymal stem cells (MSCs) have attracted significant attention in cancer research as a result of their accessibility, tumor-oriented homing capacity, and the feasibility of auto-transplantation. This review provides a comprehensive overview of current challenges in pancreatic cancer therapy, and we propose a novel strategy for using MSCs as means of delivering anticancer genes to the site of pancreas. We aim to provide a practical platform for the development of MSC-based therapy for pancreatic cancer.

引用

页码：12 / 23

页数：12

共 193 条

[11] The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-κB and c-Myc in pancreatic cancer cells [J].

Asano, T ;

Yao, YX ;

Zhu, JJ ;

Li, DH ;

Abbruzzese, JL ;

Reddy, SAG .

ONCOGENE, 2004, 23 (53) :8571-8580

[12] Apoptosis control by death and decoy receptors [J].

Ashkenazi, A ;

Dixit, VM .

CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (02) :255-260

[13] Targeting death and decoy receptors of the tumour-necrosis factor superfamily [J].

Ashkenazi, A .

NATURE REVIEWS CANCER, 2002, 2 (06) :420-430

[14] Transcoronary transplantation of progenitor cells after myocardial infarction [J].

Assmus, Birgit ;

Honold, Joerg ;

Schaechinger, Volker ;

Britten, Martina B. ;

Fischer-Rasokat, Ulrich ;

Lehmann, Ralf ;

Teupe, Claudius ;

Pistorius, Katrin ;

Martin, Hans ;

Abolmaali, Nasreddin D. ;

Tonn, Torsten ;

Dimmeler, Stefanie ;

Zeiher, Andreas M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (12) :1222-1232

[15] The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model [J].

Bardeesy, N ;

Sharpless, NE ;

DePinho, RA ;

Merlino, G .

SEMINARS IN CANCER BIOLOGY, 2001, 11 (03) :201-218

[16] Gemcitabine: A pharmacologic and clinical overview [J].

Barton-Burke, M .

CANCER NURSING, 1999, 22 (02) :176-183

[17] Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma [J].

Bergmann, Christoph ;

Strauss, Laura ;

Zeidler, Reinhard ;

Lang, Stephan ;

Whiteside, Theresa L. .

CANCER RESEARCH, 2007, 67 (18) :8865-8873

[18]

BERGMANN U, 1995, CANCER RES, V55, P2007

[19] Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources [J].

Bernardo, M. E. ;

Emons, J. A. M. ;

Karperien, M. ;

Nauta, A. J. ;

Willemze, R. ;

Roelofs, H. ;

Romeo, S. ;

Marchini, A. ;

Rappold, G. A. ;

Vukicevic, S. ;

Locatelli, F. ;

Fibbe, W. E. .

CONNECTIVE TISSUE RESEARCH, 2007, 48 (03) :132-140

[20] Gene therapy developments for pancreatic cancer [J].

Bhattacharrya, M ;

Lemoine, NR .

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2006, 20 (02) :285-298

← 1 2 3 4 5 6 7 8 9 10 →